Pyroptosis-Mediator GSDMD in Plasma: A Potent Biomarker Lung Cancer Diagnosis and Prognosis Assessment

Pyroptosis-Mediator GSDMD in Plasma: A Potent Biomarker Lung Cancer Diagnosis and Prognosis Assessment

Xuexin Liu, Fang Yu, Nan Ding, Changmei Wei, Yuhui Cui, Lijing Huo Department of Medical Laboratory, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of ChinaCorrespondence: Lijing Huo, Department of Medical Laboratory, Hebei General Hospital, 348 Heping West Road, Xinhua District, Shi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liu X, Yu F, Ding N, Wei C, Cui Y, Huo L
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-08-01
Series:	International Journal of General Medicine
Subjects:	Lung cancer Gasdermin D Biomarker Diagnosis Prognosis Inflammation
Online Access:	https://www.dovepress.com/pyroptosis-mediator-gsdmd-in-plasma-a-potent-biomarker-lung-cancer-dia-peer-reviewed-fulltext-article-IJGM
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Biological and pharmacological roles of pyroptosis in pulmonary inflammation and fibrosis: recent advances and future directions
by: Ya Liu, et al.
Published: (2024-12-01)

GSDMD-NETs in patients with sepsis-induced coagulopathy and their interaction with glycocalyx damage
by: Xiaoxi Shan, et al.
Published: (2025-07-01)

Gasdermin D‐Mediated Pyroptosis Exerts Two Opposite Effects of Resisting Enzymatic Digestion and Expanding Inflammatory Response in Acute Pancreatitis
by: Chaoxu Liu, et al.
Published: (2025-08-01)

The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score Predicts the Prognosis of Adults with Status Epilepticus: A Retrospective Study
by: Fu J, et al.
Published: (2024-11-01)

Engineering a drug-inducible pyroptosis platform enables precise tumor suppression in colorectal cancer
by: Xiang Yao, et al.
Published: (2025-12-01)

Gasdermin D is activated but does not drive neurodegeneration in SOD1G93A model of ALS: Implications for targeting pyroptosis
by: Georgia Gunner, et al.
Published: (2025-10-01)

Pan-immune-inflammation value is associated with poor prognosis in patients undergoing peritoneal dialysis
by: Fengping Zhang, et al.
Published: (2023-12-01)

IL2RG knockout mitigates polycystic ovary syndrome pathogenesis by transitioning pyroptosis to apoptosis through the GSDME pathway
by: Sailing Chen, et al.
Published: (2025-08-01)

Lung cancers biomarkers
by: D. A. Kharagezov, et al.
Published: (2022-03-01)

Intratumor Heterogeneity Predicts Prognosis in Lepidic Predominant Lung Adenocarcinoma
by: Benedikt Niedermaier, et al.
Published: (2025-01-01)

A lactate related signature for predicting prognosis and tumor microenvironment in lung adenocarcinoma
by: Ying Wang, et al.
Published: (2025-07-01)

TMCO1, as a potential biomarker of prognosis and immunotherapy response, regulates head and neck squamous cell carcinoma proliferation and migration
by: Ting Li, et al.
Published: (2025-05-01)

Reticulon 4 in Breast Cancer: A Comprehensive Analysis of its Biomarker Potential for Prognosis, Immunology, and Drug Sensitivity
by: Tuğcan Korak, et al.
Published: (2025-07-01)

Novel PET imaging biomarkers as predictors of postoperative recurrence in lung adenocarcinoma
by: Cheng Zheng, et al.
Published: (2025-05-01)

Correlation of heat shock protein 1 expression with progression and prognosis of non-small cell lung cancer
by: Rui Wang, et al.
Published: (2025-05-01)

Tumor microenvironment signatures enhances lung adenocarcinoma prognosis prediction: Implication of intratumoral microbiota
by: Fei Zhao, et al.
Published: (2025-08-01)

Systematic pan-cancer analysis identified NCOA4 as an immunological and prognostic biomarker and validated in lung adenocarcinoma
by: An Wang, et al.
Published: (2025-07-01)

Liquid biopsy based on EV biomarkers: A new frontier for early diagnosis and prognosis assessment of cancer at ESMO 2024
by: Zeping Shan, et al.
Published: (2025-12-01)

Risk prediction model for overall survival in lung cancer based on inflammatory and nutritional markers
by: Hongqi Zhou, et al.
Published: (2025-08-01)

Glycodelin is a potential biomarker for malignant tumors
by: M. V. Mnikhovich, et al.
Published: (2023-01-01)

Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network
by: Rui Li, et al.
Published: (2019-12-01)

Development and validation of a nomogram for predicting immunotherapy outcomes in lung cancer patients using clinical and blood biomarkers
by: Ting Ouyang, et al.
Published: (2025-08-01)

Comprehensive analysis of potential biomarkers for the diagnosis and prognosis of Cervical squamous cell carcinoma - based on GEO and TCGA databases
by: Yufen Chen, et al.
Published: (2025-05-01)

Biomarkers of interstitial lung disease in systemic scleroderma and their significance
by: D. V. Khorolsky, et al.
Published: (2023-02-01)

The exosomal protein biomarkers auxiliary in diagnosis of interstitial lung disease
by: Ming Dong, et al.
Published: (2025-08-01)

The heterogeneous expression patterns of serum tumor markers in non-small cell lung cancer patients are predictive factors for progression-free survival
by: Siqi Li, et al.
Published: (2025-06-01)

A prediction model based on cfDNA concentration and cfDNA methylation biomarkers for lung cancer detection
by: Li Ke, et al.
Published: (2025-08-01)

A novel prediction model for the prognosis of non-small cell lung cancer with clinical routine laboratory indicators: a machine learning approach
by: Yuli Wang, et al.
Published: (2024-11-01)

Gasdermin D mutation protects against renal ischemia reperfusion injury
by: Jennifer S. Y. Li, et al.
Published: (2025-04-01)

Real and predicted lung function after anatomical lung resections (review of literature)
by: A. L. Akopov, et al.
Published: (2021-08-01)

Impact of diabetes mellitus on osteoarthritis: a scoping review on biomarkers
by: Shi Rui Seow, et al.
Published: (2024-01-01)

Abnormal phosphorylation of human LRH1 at Ser510 predicts poor prognosis and promotes cell viability in lung squamous cell carcinoma
by: Hayato Mine, et al.
Published: (2025-04-01)

The role of PSMC4 in non-small cell lung cancer: implications for prognosis, diagnosis, and immune microenvironment modulation
by: Lili Zhu, et al.
Published: (2025-05-01)

Biomarkers for non-small cell lung cancer immunotherapy
by: D. A. Kharagezov, et al.
Published: (2021-09-01)

Exploring CISD1 as a multifaceted biomarker in cancer: Implications for diagnosis, prognosis, and immunotherapeutic response
by: Caiyue Li, et al.
Published: (2025-11-01)

The Effects Of Tumor Localization On Small Cell Lung Cancer And Its Association With Prognosis
by: Sertan Bulut, et al.
Published: (2022-03-01)

Clinical characteristics and prognosis of anti-MDA5 antibody positive dermatomyositis patients with secondary interstitial lung disease
by: MA Zongbo, et al.
Published: (2024-12-01)

The gut microbiome in lung cancer: from pathogenesis to precision therapy
by: Miao Shi, et al.
Published: (2025-08-01)

Dexamethasone conjugation to an Avidin-Nucleic-Acid-NanoASsembly eliminates the steroid plasma absorption, enhancing selective lung tropism in a murine model of pulmonary fibrosis
by: Annalisa Morelli, et al.
Published: (2025-12-01)

ITGAV as a promising diagnostic, immunological, and prognostic biomarker in pan-cancer
by: Hanyang Su, et al.
Published: (2025-08-01)